SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
136.808 0.61 (0.45%)

NAV as on 27 Feb, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Jan 31, 17)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 151.56 15.03
Strides Shasun Pharmaceuticals 98.64 9.78
Cipla Pharmaceuticals 96.66 9.59
Aurobindo Pharm Pharmaceuticals 87.27 8.65
Lupin Pharmaceuticals 80.89 8.02
Glenmark Pharmaceuticals 62.57 6.21
Natco Pharma Pharmaceuticals 48.36 4.80
Torrent Pharma Pharmaceuticals 42.90 4.25
Thyrocare Techn Services 42.82 4.25
Laurus Labs Pharmaceuticals 42.73 4.24
Sector Allocation (Jan 31, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

90.87 95.88 91.18

Services

6.61 6.06 2.80
Asset Allocation (%) (Jan 31, 17)
Class
%

Equity

97.48

Others / Unlisted

0.01

Debt

0.00

Mutual Funds

1.02

Money Market

1.34

Cash / Call

0.15

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

51.07

Top 10

74.82
Sectors
%

Top 3

97.48
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.